Athersys Comments on Misleading Article Authored by Hedge Fund
April 2, 2020
An author under the pseudonym, Alpha Exposure, published today in Seeking Alpha a highly misleading article about Athersys, its programs, its partner Healios, and its opportunities. The article contains multiple inaccuracies and falsehoods and selective and misleading use of information. The Company directs its shareholders to its previous disclosures and Healios’ recent disclosures for a comprehensive view of the company, its results and opportunities.
The company notes that the author is affiliated with a hedge fund known to pursue aggressive short selling efforts and alleged “short and distort” campaigns, in which the fund benefits from steep declines in stock price. Athersys intends to take appropriate actions to address this destructive and self-interested conduct, including notification of the SEC and other authorities.
Athersys Provides an Update on the Actions the Company is Pursuing Related to a Short and Distort Campaign
April 9, 2020
In light of the actions by Alpha Exposure and the attempt to adversely manipulate the Company’s stock price, Athersys has reported the illegal action to the SEC, FINRA, Seeking Alpha and to our legal counsel. The statements by Alpha Exposure continue to be incorrect and misleading, and the ability to comment has been removed, which we view as an explicit violation of Seeking Alpha’s stated policy of being fair and balanced. We urge our shareholders to refer to our website, our press releases, and our updated corporate presentation where we clearly state that the MUST-ARDS study reached its primary endpoint. Please refer to the Healios website and disclosures to learn about their most updated timelines for their trials.